We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-2.53%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$68.4M
AUM Growth
-$43.1M
(-39%)
Cap. Flow
-$41.1M
Cap. Flow
% of AUM
-60.1%
Top 10 Holdings %
Top 10 Hldgs %
2.86%
Holding
1,768
New
383
Increased
275
Reduced
163
Closed
946
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CoStar Group
CSGP
|
+$225K |
| 2 |
Delek US
DK
|
+$221K |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$215K |
| 4 |
PCH
PotlatchDeltic
PCH
|
+$201K |
| 5 |
HEES
H&E Equipment Services
HEES
|
+$200K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$470K |
| 2 |
Unisys
UIS
|
+$454K |
| 3 |
Schrodinger
SDGR
|
+$428K |
| 4 |
Leggett & Platt
LEG
|
+$408K |
| 5 |
Sutro Biopharma
STRO
|
+$394K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Industrials | 14.9% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Healthcare | 14.06% |
| 5 | Technology | 13.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Nutanix
NTNX
$14.7B
| $90.8K | 0.13% |
1,598
+1,294
| +426% | +$79.4K |
|
352
Helen of Troy
HELE
$653M
| $90.7K | 0.13% |
978
-2,059
| -68% | -$209K |
|
353
Atkore
ATKR
$2.57B
| $90.5K | 0.13% |
+671
| New | +$107K |
|
354
Credo Technology Group
CRDO
$40.4B
| $90.2K | 0.13% |
2,823
+2,056
| +268% | +$45.5K |
|
355
Zebra Technologies
ZBRA
$12.5B
| $89.9K | 0.13% |
+291
| New | +$88.5K |
|
356
Live Oak Bancshares
LOB
$1.97B
| $89.8K | 0.13% |
+2,561
| New | +$90.7K |
|
357
Vistra
VST
$56.3B
| $89.7K | 0.13% |
+1,043
| New | +$87.3K |
|
358
Southern Copper
SCCO
$142B
| $89.5K | 0.13% |
+888
| New | +$94.5K |
|
359
Adobe
ADBE
$88.6B
| $89.4K | 0.13% |
161
-285
| -64% | -$138K |
|
|
MORF
360
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $89.4K | 0.13% |
+2,625
| New | +$77.8K |
|
|
SFBS
361
ServisFirst Bancshares
SFBS
$4.82B
| $88.4K | 0.13% |
1,399
+1,398
| +139,800% | +$86.3K |
|
362
Nature's Sunshine
NATR
$359M
| $88.3K | 0.13% |
+5,858
| New | +$100K |
|
363
Peoples Bancorp
PEBO
$1.44B
| $88K | 0.13% |
2,934
-1,417
| -33% | -$41.1K |
|
364
Phathom Pharmaceuticals
PHAT
$916M
| $87.6K | 0.13% |
8,503
-10,877
| -56% | -$112K |
|
365
Dyne Therapeutics
DYN
$4.06B
| $87.5K | 0.13% |
2,479
-5,073
| -67% | -$147K |
|
366
Nice
NICE
$5.27B
| $87.4K | 0.13% |
508
+443
| +682% | +$91.1K |
|
367
Simulations Plus
SLP
$371M
| $87.2K | 0.13% |
1,794
+401
| +29% | +$18.9K |
|
368
Corning
GLW
$130B
| $87.2K | 0.13% |
2,245
-3,273
| -59% | -$114K |
|
|
ENV
369
DELISTED
ENVESTNET, INC.
ENV
| $86.9K | 0.13% |
+1,389
| New | +$87.4K |
|
|
ITCI
370
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $86.8K | 0.13% |
1,268
-899
| -41% | -$62.4K |
|
371
Sierra Bancorp
BSRR
$550M
| $86.3K | 0.13% |
+3,858
| New | +$78.9K |
|
372
Collegium Pharmaceutical
COLL
$1.16B
| $86.1K | 0.13% |
2,675
+435
| +19% | +$15.1K |
|
373
APA Corp
APA
$12.9B
| $85.8K | 0.13% |
+2,916
| New | +$90.2K |
|
374
Uber
UBER
$141B
| $85.8K | 0.13% |
1,180
-1,243
| -51% | -$86.4K |
|
375
Olin
OLN
$2.68B
| $85K | 0.12% |
+1,802
| New | +$96.4K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q2 2024 Portfolio in Review
As of Q2 2024, EntryPoint Capital held 1,768 positions worth $68.4M, down 39% from $112M the previous quarter. Its ten largest holdings account for 2.9% of the portfolio.
EntryPoint Capital withdrew a net $41.1M in Q2 2024, closing 946 positions and reducing 163 holdings. Its most notable exit was GXO Logistics, an estimated $470K position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, EntryPoint Capital opened a new position in CoStar Group worth $197K.
- EntryPoint Capital's largest Q2 2024 buy was CoStar Group: 2,657 shares worth $197K.
- EntryPoint Capital added most to Martin Marietta Materials in Q2 2024, an estimated $181K increase.
- EntryPoint Capital's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $327K.
- EntryPoint Capital fully exited GXO Logistics in Q2 2024, selling an estimated $470K.
- EntryPoint Capital's ten largest holdings make up 2.9% of its $68.4M portfolio in Q2 2024.
- EntryPoint Capital opened 383 new positions and closed 946 in Q2 2024.
- EntryPoint Capital's portfolio value fell 39% quarter-over-quarter to $68.4M.
Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.